U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C28H35N7O4S
Molecular Weight 565.687
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3-ETHYL-5-(5-((4-ETHYLPIPERAZIN-1-YL)SULFONYL)-2-PROPOXYPHENYL)-2-(PYRIDIN-2-YLMETHYL)-2,6-DIHYDRO-7H-PYRAZOLO(4,3-D)PYRIMIDIN-7-ONE

SMILES

CCCOC1=CC=C(C=C1C2=NC3=C(CC)N(CC4=NC=CC=C4)N=C3C(=O)N2)S(=O)(=O)N5CCN(CC)CC5

InChI

InChIKey=NIBCDDKWFDEBEP-UHFFFAOYSA-N
InChI=1S/C28H35N7O4S/c1-4-17-39-24-11-10-21(40(37,38)34-15-13-33(6-3)14-16-34)18-22(24)27-30-25-23(5-2)35(32-26(25)28(36)31-27)19-20-9-7-8-12-29-20/h7-12,18H,4-6,13-17,19H2,1-3H3,(H,30,31,36)

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia.
2011-02
Patents

Patents

Name Type Language
UK-343664
Preferred Name English
3-ETHYL-5-(5-((4-ETHYLPIPERAZIN-1-YL)SULFONYL)-2-PROPOXYPHENYL)-2-(PYRIDIN-2-YLMETHYL)-2,6-DIHYDRO-7H-PYRAZOLO(4,3-D)PYRIMIDIN-7-ONE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID1047289
Created by admin on Mon Mar 31 22:48:53 GMT 2025 , Edited by admin on Mon Mar 31 22:48:53 GMT 2025
PRIMARY
PUBCHEM
135430996
Created by admin on Mon Mar 31 22:48:53 GMT 2025 , Edited by admin on Mon Mar 31 22:48:53 GMT 2025
PRIMARY
CAS
215297-27-1
Created by admin on Mon Mar 31 22:48:53 GMT 2025 , Edited by admin on Mon Mar 31 22:48:53 GMT 2025
PRIMARY
FDA UNII
3ES85MM31Y
Created by admin on Mon Mar 31 22:48:53 GMT 2025 , Edited by admin on Mon Mar 31 22:48:53 GMT 2025
PRIMARY